New Delhi, Feb 18 (IANS) The immune systems of cancer patients may play a significant role in their treatment outcomes, according to a study on Tuesday.
In the study, researchers at the University College London and the Francis Crick Institute found that cancer patients with a higher number of immune cells in their blood have a better survival rate.
They used a pioneering technique — Immune Lymphocyte Estimation from Nucleotide Sequencing (ImmuneLENS), which enables researchers to calculate the proportion of T cells and B cells (types of immune cells) from whole genome sequencing (WGS) data.
The team analysed over 90,000 WGS samples — both of healthy individuals and cancer patients. The findings described in the journal Nature Genetics showed that cancer patients had a lower proportion of T cells circulating in the blood compared to healthy individuals.
Further, T cell proportion was found to be a strong predictor of cancer outcomes, with higher proportions associated with 47 per cent fewer deaths over five years after surgery.
This effect was still significant when accounting for age, cancer stage, and across all cancer types — biological markers which can be added to current genetic diagnostic tests to help clinicians with more information on which to base treatment plans, said the researchers.
Professor Nicholas McGranahan, senior author of the study from UCL Cancer Institute, said while most immune system analysis until now has focused on the tumour itself, with the new tool, doctors “may be able to predict how long a cancer patient will survive better than the number of T cells in the tumour alone”.
The study also showed that in people with cancer, particularly males, the proportion of immune cells in the blood diminishes faster. However, the reason behind these sexual differences remains unclear.
They also observed that individuals who were seemingly healthy at the time their sample was taken for sequencing, who subsequently went on to develop cancer, had below-average levels of B cells in their blood.
This could be because of undiagnosed early-stage cancer, or pre-cancerous changes to the immune system that could potentially have been an early sign of disease or even a factor in cancer development.
This information could be used in the future for cancer early detection or to help clinicians understand how the patient may respond to treatment, said the researchers.
–IANS
rvt/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
